Clinical Trial Update: Safety and Efficacy of SA09012 in Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial SA09012 in mild to moderate bronchial asthma has completed, with reported safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SA09012

Snippet

Sponsor: SamA Pharmaceutical Co., Ltd | Conditions: Mild to Moderate Bronchial Asthma | Phase 2 | Status: COMPLETED